9 Meters Biopharma, Inc. (NMTR) financial statements (2022 and earlier)

Company profile

Business Address 8480 HONEYCUTT ROAD
RALEIGH, NC 27615
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments46,99337,9264,6685,7294261,453
Cash and cash equivalents46,99337,9264,6685,7294261,453
Receivables    90856
Inventory, net of allowances, customer advances and progress billings    1011,105
Inventory    1011,105
Deferred costs   105  
Other undisclosed current assets2,9921,00155558046619
Total current assets:49,98538,9275,2236,4146634,033
Noncurrent Assets
Operating lease, right-of-use asset16721543
Property, plant and equipment16112535  
Intangible assets, net (including goodwill)     2,417
Intangible assets, net (excluding goodwill)     2,417
Deposits noncurrent assets    1414
Other noncurrent assets6666  
Total noncurrent assets:1882327441142,431
TOTAL ASSETS:50,17439,1595,2976,4546776,464
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities8,4026,7798,6384,5471,1332,054
Accounts payable2,4341,4883,8903,619441268
Accrued liabilities5,9685,2904,7488266921,786
Interest and dividends payable 0 102  
Debt 143,2275,197 38
Deferred compensation liability  41   
Derivative instruments and hedges, liabilities 7408370  
Due to related parties    3344
Customer refund liability    1251,840
Other undisclosed current liabilities55492,597 1,359 
Total current liabilities:8,4576,84814,91110,1132,6503,976
Noncurrent Liabilities
Long-term debt and lease obligation113168    
Operating lease, liability113168 
Other undisclosed noncurrent liabilities(113)(168)    
Total noncurrent liabilities:113168    
Total liabilities:8,5707,01614,91110,1132,6503,976
Stockholders' equity
Stockholders' equity attributable to parent41,60332,142(9,614)(3,659)(1,973)2,488
Common stock26204311
Additional paid in capital210,418164,18360,94739,85438,03934,575
Accumulated deficit(168,841)(132,061)(70,565)(43,516)(40,013)(32,088)
Total stockholders' equity:41,60332,142(9,614)(3,659)(1,973)2,488
TOTAL LIABILITIES AND EQUITY:50,17439,1595,2976,4546776,464

Income statement (P&L) ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues
(Revenue, Net)
    1,8834,065
Cost of revenue
(Cost of Goods and Services Sold)
    (1,947)(3,329)
Gross profit:    (64)736
Operating expenses(36,762)(60,878)(25,549)(18,224)(8,888)(6,679)
Other undisclosed operating income  51,09736,448  
Operating income (loss):(36,762)(60,878)25,54918,224(8,952)(5,943)
Nonoperating income (expense)(17)(619)(1,500)(5,938)1,027 
Interest and debt expense(47)(4,046)(1,049)(6,152)200(825)
Income (loss) from continuing operations before equity method investments, income taxes:(36,827)(65,543)22,9996,134(7,725)(6,768)
Other undisclosed income (loss) from continuing operations before income taxes474,046(50,048)(30,296)(200)557
Loss from continuing operations before income taxes:(36,779)(61,496)(27,049)(24,162)(7,925)(6,211)
Income tax expense     (2)
Net loss attributable to parent:(36,779)(61,496)(27,049)(24,162)(7,925)(6,213)
Other undisclosed net loss available to common stockholders, basic    (896) 
Net loss available to common stockholders, diluted:(36,779)(61,496)(27,049)(24,162)(8,821)(6,213)

Comprehensive Income ($ in thousands)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(36,779)(61,496)(27,049)(24,162)(7,925)(6,213)
Comprehensive loss, net of tax, attributable to parent:(36,779)(61,496)(27,049)(24,162)(7,925)(6,213)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: